Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5 T with 3.0 T

[1]  B E Kendall,et al.  The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. , 1987, Brain : a journal of neurology.

[2]  G. Comi,et al.  Resolution‐dependent estimates of lesion volumes in magnetic resonance imaging studies of the brain in multiple sclerosis , 1995, Annals of neurology.

[3]  J. Duyn,et al.  Design of a SENSE‐optimized high‐sensitivity MRI receive coil for brain imaging , 2002, Magnetic resonance in medicine.

[4]  Seth E. Bouvier,et al.  Comparison of Multiple Sclerosis Lesions at 1.5 and 3.0 Tesla , 2003, Investigative radiology.

[5]  C. Polman,et al.  Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. , 2004, Archives of neurology.

[6]  À. Rovira,et al.  Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[7]  3.0-T high-field magnetic resonance imaging of the female pelvis: preliminary experiences , 2005, European Radiology.

[8]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[9]  H. Imhof,et al.  [The importance of magnetic field strength in the MR diagnosis of multiple sclerosis: a comparison of 0.5 and 1.5 T]. , 1993, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[10]  R. Kakigi,et al.  Disseminated lesions at presentation in patients with optic neuritis. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[11]  A. A. Eisen,et al.  MRI in the diagnosis of MS , 1988, Neurology.

[12]  S. L. Galetta,et al.  The utility of MRI in suspected MS , 2003, Neurology.

[13]  C. Kuhl,et al.  Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience. , 2005, Radiology.

[14]  W. Heiss,et al.  New diagnostic criteria for multiple sclerosis , 2002, Annals of neurology.

[15]  M Filippi,et al.  Comparison of MR pulse sequences in the detection of multiple sclerosis lesions. , 1997, AJNR. American journal of neuroradiology.

[16]  C P Langlotz,et al.  MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5 T and 4 T. , 1998, AJNR. American journal of neuroradiology.

[17]  D. Goodin,et al.  The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. , 2004, Neurology.

[18]  Fritz Schick,et al.  Whole-body MRI at high field: technical limits and clinical potential , 2005, European Radiology.

[19]  David H. Miller,et al.  Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis , 2002, Annals of neurology.

[20]  Stefan Maderwald,et al.  Comparison of volume, four- and eight-channel head coils using standard and parallel imaging , 2005, European Radiology.

[21]  M. Eliasziw,et al.  MR imaging field strength: prospective evaluation of the diagnostic accuracy of MR for diagnosis of multiple sclerosis at 0.5 and 1.5 T. , 1995, Radiology.

[22]  M. Gutberlet,et al.  Influence of high magnetic field strengths and parallel acquisition strategies on image quality in cardiac 2D CINE magnetic resonance imaging: comparison of 1.5 T vs. 3.0 T , 2005, European Radiology.

[23]  H. Schild.  [Clinical highfield MR]. , 2005, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[24]  F. Barkhof,et al.  Interobserver agreement for diagnostic MRI criteria in suspected multiple sclerosis , 1999, Neuroradiology.

[25]  P. O'Brien,et al.  Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. , 2003, Neurology.

[26]  K. Albertsson-Wikland,et al.  Pubertal Growth Assessment , 2003, Hormone Research in Paediatrics.

[27]  P M Matthews,et al.  Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis , 2004, Annals of neurology.

[28]  H. Imhof,et al.  Bedeutung der Magnetfeldstärke in der MR-Diagnostik der multiplen Sklerose : ein Vergleich von 0,5 und 1,5 T , 1993 .

[29]  J. Gieseke,et al.  Lung MRI at 3.0 T: a comparison of helical CT and high-field MRI in the detection of diffuse lung disease , 2005, European Radiology.

[30]  C. Kuhl,et al.  Does high-field MR imaging have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic mr imaging criteria for multiple sclerosis? , 2006, AJNR. American journal of neuroradiology.

[31]  H. Schild,et al.  Imaging of inflammatory lesions at 3.0 Tesla in patients with clinically isolated syndromes suggestive of multiple sclerosis: a comparison of fluid-attenuated inversion recovery with T2 turbo spin-echo , 2006, European Radiology.

[32]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[33]  F. Barkhof,et al.  Interscanner variation in brain MRI lesion load measurements in MS: Implications for clinical trials , 1997, Neurology.

[34]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[35]  H. Schild,et al.  Klinische Hochfeld-MRT , 2005 .

[36]  C Becker,et al.  Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. , 1996, Brain : a journal of neurology.

[37]  J Sastre-Garriga,et al.  New diagnostic criteria for multiple sclerosis , 2003, Neurology.

[38]  J H Simon,et al.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. , 2000, The New England journal of medicine.

[39]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.